Dissociation of the effects of amylin on osteoblast proliferation and bone resorption

J. Cornish, K. E. Gallon, C. Q X Lin, C. L. Xiao, T. B. Mulvey, D. H. Coy, Garth Cooper, I. R. Reid

Research output: Contribution to journalArticlepeer-review


This study assesses the structure-activity relationships of the actions of amylin on bone. In fetal rat osteoblasts, only intact amylin and amylin(1- 8) stimulated cell proliferation (half-maximal concentrations 2.0 X 10-11 and 2.4 X 10-10 M, respectively). Amylin-(837), COOH terminally deamidated amylin, reduced amylin, and reduced amylin-(1-8) (reduction results in cleavage of the disulfide bond) were without agonist effect but acted as antagonists to the effects of both amylin and amylin-(1-8). Calcitonin gene- related peptide-(8-37) also antagonized the effects of amylin and amylin-(1- 8) on osteoblasts but was substantially less potent in this regard than amylin-(8-37). In contrast, inhibition of bone resorption in neonatal mouse calvariae only occurred with the intact amylin molecule and was not antagonized by any of these peptides. The rate of catabolism of the peptides in calvarial cultures was not accelerated in comparison with that of intact amylin. This dissociation of the actions of amylin suggests that it acts through two separate receptors, one on the osteoclast (possibly the calcitonin receptor) and a second on the osteoblast.
Original languageEnglish
Pages (from-to)E827-E833
JournalAJP: Endocrinology and Metabolism
Issue number5
Publication statusPublished - May 1998


  • Amylin molecular fragments
  • Amylin peptide blockers
  • Bone formation
  • Structure-activity relationships


Dive into the research topics of 'Dissociation of the effects of amylin on osteoblast proliferation and bone resorption'. Together they form a unique fingerprint.

Cite this